Indivior PLC (INDV)
USD 11.98
(3.72%)
USD 11.98
(3.72%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 907 Million USD | 27.63% |
| 2022 | 715.75 Million USD | 11.86% |
| 2021 | 639.87 Million USD | 11.58% |
| 2020 | 573.49 Million USD | -11.78% |
| 2019 | 650.04 Million USD | -21.23% |
| 2018 | 825.24 Million USD | -19.5% |
| 2017 | 1.02 Billion USD | 19.48% |
| 2016 | 858.07 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 183.37 Million USD | -20.26% |
| 2024 Q3 | 238 Million USD | 29.79% |
| 2024 Q1 | 229.97 Million USD | -6.23% |
| 2023 Q2 | 226.1 Million USD | 6.08% |
| 2023 FY | 913.49 Million USD | 27.63% |
| 2023 Q4 | 245.24 Million USD | 16.18% |
| 2023 Q1 | 213.15 Million USD | 6.01% |
| 2023 Q3 | 211.08 Million USD | -6.65% |
| 2022 FY | 715.75 Million USD | 11.86% |
| 2022 Q4 | 201.06 Million USD | 12.66% |
| 2022 Q3 | 178.46 Million USD | 2.75% |
| 2022 Q2 | 173.68 Million USD | 6.2% |
| 2022 Q1 | 163.54 Million USD | -9.91% |
| 2021 FY | 639.87 Million USD | 11.58% |
| 2021 Q4 | 181.54 Million USD | 0.0% |
| 2020 FY | 573.49 Million USD | -11.78% |
| 2019 FY | 650.04 Million USD | -21.23% |
| 2018 FY | 825.24 Million USD | -19.5% |
| 2017 FY | 1.02 Billion USD | 19.48% |
| 2016 FY | 858.07 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Esperion Therapeutics, Inc. | 73.06 Million USD | -1141.326% |
| Theratechnologies Inc. | 62.12 Million USD | -1359.866% |
| Safety Shot Inc | -74.45 Thousand USD | 1218252.759% |
| Cosmos Health Inc. | 4.34 Million USD | -20752.641% |
| Cronos Group Inc. | 6.99 Million USD | -12874.016% |
| Ironwood Pharmaceuticals, Inc. | 441.16 Million USD | -105.594% |
| Kala Pharmaceuticals, Inc. | -303 Thousand USD | 299439.934% |
| Organogenesis Holdings Inc. | 309.79 Million USD | -192.779% |
| Universe Pharmaceuticals INC | 10.07 Million USD | -8899.909% |
| ProPhase Labs, Inc. | 16.23 Million USD | -5485.319% |
| Sonoma Pharmaceuticals, Inc. | 4.74 Million USD | -19014.858% |
| Dynavax Technologies Corporation | 182.11 Million USD | -398.031% |
| Radius Health, Inc. | 307.71 Million USD | -194.757% |
| China SXT Pharmaceuticals, Inc. | 553.97 Thousand USD | -163626.982% |
| Alvotech | -69.42 Million USD | 1406.502% |
| Sunshine Biopharma, Inc. | 8.33 Million USD | -10776.381% |
| Alpha Teknova, Inc. | 10.29 Million USD | -8709.246% |
| Intra-Cellular Therapies, Inc. | 430.62 Million USD | -110.624% |
| SCYNEXIS, Inc. | 124.51 Million USD | -628.415% |
| Harrow Health, Inc. | 90.55 Million USD | -901.623% |
| Biofrontera Inc. | 16.62 Million USD | -5354.983% |
| DURECT Corporation | 6.83 Million USD | -13177.705% |
| Supernus Pharmaceuticals, Inc. | 523.74 Million USD | -73.177% |
| ANI Pharmaceuticals, Inc. | 305.3 Million USD | -197.082% |
| OptiNose, Inc. | 62.35 Million USD | -1354.598% |
| RedHill Biopharma Ltd. | 3.05 Million USD | -29597.073% |
| Aquestive Therapeutics, Inc. | 29.75 Million USD | -2948.535% |
| Cumberland Pharmaceuticals Inc. | 33.48 Million USD | -2608.603% |
| SIGA Technologies, Inc. | 122.09 Million USD | -642.882% |
| Lifecore Biomedical, Inc. | 41.85 Million USD | -2067.264% |
| Shineco, Inc. | 882.16 Thousand USD | -102714.883% |
| Phibro Animal Health Corporation | 312.48 Million USD | -190.252% |
| Procaps Group S.A. | 239.56 Million USD | -278.597% |
| TherapeuticsMD, Inc. | 1.3 Million USD | -69562.058% |
| Regencell Bioscience Holdings Limited | -745.58 Thousand USD | 121748.954% |
| Viatris Inc. | 6.43 Billion USD | 85.913% |
| Sunshine Biopharma, Inc. | 8.33 Million USD | -10776.381% |
| Rockwell Medical, Inc. | 8.7 Million USD | -10320.496% |
| Incannex Healthcare Limited | 12 Thousand USD | -7558233.333% |
| Aytu BioPharma, Inc. | 54.58 Million USD | -1561.598% |
| Tilray Brands, Inc. | 223.35 Million USD | -306.087% |
| Collegium Pharmaceutical, Inc. | 326.16 Million USD | -178.077% |
| PetIQ, Inc. | 252.74 Million USD | -258.867% |
| Silver Spike Investment Corp. | 8.1 Million USD | -11093.939% |
| Neurocrine Biosciences, Inc. | 1.84 Billion USD | 50.904% |
| Journey Medical Corporation | 52.52 Million USD | -1626.928% |
| Alimera Sciences, Inc. | 61.17 Million USD | -1382.753% |
| Petros Pharmaceuticals, Inc. | 4.19 Million USD | -21540.745% |
| Assertio Holdings, Inc. | 125.04 Million USD | -625.316% |
| Shuttle Pharmaceuticals Holdings, Inc. | -6811.00 USD | 13316793.584% |
| Embecta Corp. | 749.9 Million USD | -20.949% |
| Cyclo Therapeutics, Inc. | -2.41 Million USD | 37732.107% |
| Procaps Group, S.A. | 239.56 Million USD | -278.597% |
| PainReform Ltd. | -15 Thousand USD | 6046766.667% |
| Avadel Pharmaceuticals plc | 27.11 Million USD | -3244.765% |
| Hempacco Co., Inc. | -1.21 Million USD | 74699.061% |
| Talphera, Inc. | -4.89 Million USD | 18629.111% |
| Pacira BioSciences, Inc. | 490.3 Million USD | -84.985% |
| Alvotech | -69.42 Million USD | 1406.502% |
| Lantheus Holdings, Inc. | 709.54 Million USD | -27.829% |
| Kamada Ltd. | 52.59 Million USD | -1624.572% |
| Currenc Group, Inc. | 17.35 Million USD | -5125.767% |
| Evoke Pharma, Inc. | 4.97 Million USD | -18117.42% |
| Flora Growth Corp. | 17.73 Million USD | -5013.316% |
| Cyclo Therapeutics, Inc. | -2.41 Million USD | 37732.107% |
| Evolus, Inc. | 140.52 Million USD | -545.432% |
| HUTCHMED (China) Limited | 453.55 Million USD | -99.977% |
| Amphastar Pharmaceuticals, Inc. | 343.96 Million USD | -163.687% |
| Akanda Corp. | 111.44 Thousand USD | -813725.158% |